Advertisement
U.S. Markets closed

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed Price. Currency in AUD
13.13+0.02 (+0.15%)
At close: 04:10PM AEDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
231,925
231,925
14,553
-
-
Gross Profit
231,925
231,925
14,553
-
-
Operating Expense
32,714
32,714
16,159
11,438
9,532
Operating Income
199,211
199,211
-1,606
-11,438
-9,532
Net Non Operating Interest Income Expense
5,687
5,687
391
41
147
Other Income Expense
225
225
1,389
3,595
186
Pretax Income
205,140
205,140
184
-7,794
-9,193
Tax Provision
48,059
48,059
0
0
0
Net Income Common Stockholders
157,081
157,081
184
-7,794
-9,193
Basic EPS
0.44
1.24
0.00
-0.07
-0.09
Diluted EPS
0.44
1.20
0.00
-0.07
-0.09
Basic Average Shares
126,266
127,070
125,966
117,770
107,057
Diluted Average Shares
126,266
130,792
125,966
117,770
107,057
Net Income from Continuing & Discontinued Operation
157,081
157,081
184
-7,794
-9,193
Normalized Income
157,081
157,081
184
-7,794
-9,193
Interest Income
5,687
5,687
391
41
147
Net Interest Income
5,687
5,687
391
41
147
EBIT
199,211
199,211
-1,606
-11,438
-9,532
EBITDA
199,228
199,228
-1,596
-11,430
-9,526
Reconciled Depreciation
17
17
10
8
6
Net Income from Continuing Operation Net Minority Interest
157,081
157,081
184
-7,794
-9,193
Normalized EBITDA
199,228
199,228
-1,596
-11,430
-9,526
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0